"Scienture Holdings: Innovating CNS and Cardiovascular Treatments with Losartan"

Scienture Holdings is advancing treatments for central nervous system and cardiovascular diseases in the United States, focusing on innovative applications of Losartan to manage hypertension and reduce the risk of stroke.

• Scienture Holdings, Inc. is dedicated to the development of Losartan as a key medication for treating hypertension and improving cardiovascular health in the United States.
• The companys Scienture segment is actively researching Losartan and its potassium component, exploring its effectiveness in suspension (chemistry) formulations for enhanced patient outcomes.
• Recent studies indicate that effective management of blood pressure using Losartan can significantly lower the incidence of stroke among patients with hypertension, marking a breakthrough in health care.
• Through its Integra segment, Scienture Holdings also engages in the wholesale distribution of licensed pharmaceuticals, including generics that complement its focus on Losartan and related therapies.
• The United States Government Publishing Office has recognized Scientures innovative approaches to nursing home care, particularly in managing chronic conditions like hypertension with Losartan based treatments.